Breast Cancer Clinical Trial

Exercise Intervention Prior to CRS-HIPEC: Feasibility & Impact

Summary

Our objective is to initiate an exercise program for patients with advanced GI or Gyn cancer, as prehabilitation prior to surgery. The objective of the prehabilitation program is to reduce complication rates and improve the length and quality of survival for patients with abdominal cancer. The prehabilitation program will be offered to patients who are eligible for and consent to cytoreductive surgery (CRS) and heated intraperitoneal chemotherapy (HIPEC)

View Full Description

Full Description

Our objective is to assess the feasibility and impact of implementing an exercise program for patients with advanced GI or Gyn cancer, as prehabilitation prior to surgery. The objective of the prehabilitation program is to reduce complication rates and improve the length and quality of survival for patients with abdominal cancer. The prehabilitation program will be offered to patients who are eligible for and consent to cytoreductive surgery (CRS) and heated intraperitoneal chemotherapy (HIPEC).

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Patients with peritoneal metastasis from appendix, colon, small bowel, endometrium, ovary or any other GI or Gyn primary tumor
Patients should be eligible for and consent to surgery with the intention of performing CRS / HIPEC at Penn State Hershey Medical Center. Eligibility for CRS/HIPEC is a clinical determination based on a combination of factors including radiographic extent of disease, tumor histology and medical fitness for surgery
Subjects who are explored but found to be unresectable will be included.
Male or female.
Patients should be age 18 or above.
Surgery is planned for not less than 6 weeks and no more than 10 weeks from consultation

Exclusion Criteria:

Patients who do not consent to surgery.
Patients who require urgent surgery, sooner than 6 weeks
Patients receiving neoadjuvant chemotherapy, with no surgical date planned before 10 weeks from consultation. These patients can be enrolled at the time of the follow-up visit, as long as they meet above criteria
Patients not fluent in English
Pregnant women
Prisoners
Patients with Cognitive Impairment

Study is for people with:

Breast Cancer

Estimated Enrollment:

12

Study ID:

NCT04731441

Recruitment Status:

Terminated

Sponsor:

Milton S. Hershey Medical Center

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Penn State Hershey Medical Center
Hershey Pennsylvania, 17033, United States

How clear is this clinincal trial information?

Study is for people with:

Breast Cancer

Estimated Enrollment:

12

Study ID:

NCT04731441

Recruitment Status:

Terminated

Sponsor:


Milton S. Hershey Medical Center

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.